nawet na dfugoletnie przezycie. Czynniki prognostyczne analizowane w pracy nie wykazafy znamiennego statystycznie wpfywu na czas przezycia. Nadal brak scisfych kryteri6w kwalifikacji do zabiegu zmusza chirurga do indywidualnej oceny kazdego przypadku i wyboru maksymalnej korzysci dla pacjenta przy j
✦ LIBER ✦
231. Synchronous and metachronous bilateral breast cancer – A comparison of clinical, histopathological features of the first and second primary breast cancer and BRCA 1 and 2 mutations
✍ Scribed by E. Nowicka; J. Rogozińska; E. Grzybowska; K. Behrendt; A. Mucha-Małecka; R. Tarnawski
- Publisher
- Wielkopolskie Centrum Onkologii
- Year
- 2003
- Tongue
- Polish
- Weight
- 187 KB
- Volume
- 8
- Category
- Article
- ISSN
- 1507-1367
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
209. Synchronous and metachronous bilate
✍
E. Nowicka; J. Rogozińska; E. Grzybowska; K. Behrendt; A. Mucha-Małecka; R. Tarn
📂
Article
📅
2003
🏛
Wielkopolskie Centrum Onkologii
🌐
Polish
⚖ 107 KB
Frequency of BRCA1 and BRCA2 mutations i
✍
Susan A.J. Vaziri; Lisa M. Krumroy; Majid Rostai; Graham Casey
📂
Article
📅
2000
🏛
John Wiley and Sons
🌐
English
⚖ 29 KB
👁 2 views
BRCA1/BRCA2mutation status and clinical-
✍
Laura Ottini; Piera Rizzolo; Ines Zanna; Mario Falchetti; Giovanna Masala; Ketty
📂
Article
📅
2008
🏛
Springer US
🌐
English
⚖ 437 KB
Contribution of BRCA1 and BRCA2 germ-lin
✍
Valerie Bonadona; Olga M. Sinilnikova; Sandrine Chopin; Antonis C. Antoniou; Her
📂
Article
📅
2005
🏛
John Wiley and Sons
🌐
English
⚖ 154 KB
👁 2 views
## Abstract The prevalence of __BRCA1/2__ germ‐line mutations was assessed in a prospective population‐based series of early‐onset breast cancer (BC) patients in France, and the usefulness of a clinical assessment of hereditary BC risk, based on multiple criteria including pedigree structure, was e
Results of the first phase 1 clinical tr
✍
Mark G. Carmichael; Linda C. Benavides; Jarrod P. Holmes; Jeremy D. Gates; Eliza
📂
Article
📅
2010
🏛
John Wiley and Sons
🌐
English
⚖ 424 KB
👁 1 views